BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang J, Liu Z, Zeng B, Hu G, Gan R. Epstein-Barr virus-associated gastric cancer: A distinct subtype. Cancer Lett 2020;495:191-9. [PMID: 32979463 DOI: 10.1016/j.canlet.2020.09.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Liang Y, Liu W, Zhao M, Shi D, Zhang Y, Luo B. Nuclear respiratory factor 1 promotes the progression of EBV-associated gastric cancer and maintains EBV latent infection. Virus Genes 2023;59:204-14. [PMID: 36738378 DOI: 10.1007/s11262-023-01970-8] [Reference Citation Analysis]
2 Zhang Y, Xiang X, Zhou S, Dindar DA, Wood S, Zhang Z, Shan B, Zhao L. Relationship between pathogenic microorganisms and the occurrence of esophageal carcinoma based on pathological type: a narrative review. Expert Rev Gastroenterol Hepatol 2023;:1-9. [PMID: 36896656 DOI: 10.1080/17474124.2023.2189099] [Reference Citation Analysis]
3 Liu S, Deng Z, Zhu J, Ma Z, Tuo B, Li T, Liu X. Gastric immune homeostasis imbalance: An important factor in the development of gastric mucosal diseases. Biomed Pharmacother 2023;161:114338. [PMID: 36905807 DOI: 10.1016/j.biopha.2023.114338] [Reference Citation Analysis]
4 Xia C, Su J, Liu C, Mai Z, Yin S, Yang C, Fu L. Human microbiomes in cancer development and therapy. MedComm (2020) 2023;4:e221. [PMID: 36860568 DOI: 10.1002/mco2.221] [Reference Citation Analysis]
5 Wah NW, Mok Y, Omar N, Chang KTE, Tay TKY, Hue SS, Lee VKM. Clinicopathologic and Molecular Characteristics of Epstein-Barr Virus-Associated Smooth Muscle Tumor Compared With Those of Leiomyoma and Leiomyosarcoma. Mod Pathol 2023;36:100127. [PMID: 36965331 DOI: 10.1016/j.modpat.2023.100127] [Reference Citation Analysis]
6 Duque X, Mendoza E, Morán S, Suárez-Arriaga MC, Morales-Sánchez A, Fontes-Lemus JI, Domínguez-Martínez DA, Fuentes-Pananá EM. Epstein-Barr Virus Infection Is Associated with Elevated Hepcidin Levels. Int J Mol Sci 2023;24. [PMID: 36675141 DOI: 10.3390/ijms24021630] [Reference Citation Analysis]
7 Min Y, Wei X, Xia X, Wei Z, Li R, Jin J, Liu Z, Hu X, Peng X. Hepatitis B virus infection: An insight into the clinical connection and molecular interaction between hepatitis B virus and host extrahepatic cancer risk. Front Immunol 2023;14:1141956. [PMID: 36936956 DOI: 10.3389/fimmu.2023.1141956] [Reference Citation Analysis]
8 Xu M, Zhang L, Feng J, Yang S, Wang Y, Wang Y, Chen M, Zhou L, Zhang J, Qin Q. Establishment and characterization of two Epstein-Barr virus-positive gastric cancer cell lines with epitheliotropic M81 strain undergoing distinct viral and altered cellular expression profiles. J Med Virol 2023;95:e28387. [PMID: 36478267 DOI: 10.1002/jmv.28387] [Reference Citation Analysis]
9 Liang M, Wang X, Cai D, Guan W, Shen X. Tissue-resident memory T cells in gastrointestinal tumors: turning immune desert into immune oasis. Front Immunol 2023;14:1119383. [PMID: 36969190 DOI: 10.3389/fimmu.2023.1119383] [Reference Citation Analysis]
10 Zhao MH, Liu W, Li P, Liu L, Zhang X, Luo B. Sequence analysis of Epstein-Barr virus RPMS1 gene in malignant hematopathy of Northern China. J Med Virol 2023;95:e28238. [PMID: 36258294 DOI: 10.1002/jmv.28238] [Reference Citation Analysis]
11 Schulz WA. Stomach Cancer. Molecular Biology of Human Cancers 2023. [DOI: 10.1007/978-3-031-16286-2_18] [Reference Citation Analysis]
12 Kinami S, Yamada S, Takamura H. Confusion and prospects for carcinogenesis of gastric adenoma and dysplasia: What is the correct answer currently? World J Gastroenterol 2022; 28(48): 6900-6908 [DOI: 10.3748/wjg.v28.i48.6900] [Reference Citation Analysis]
13 Hassan STS, Šudomová M. Molecular Mechanisms of Flavonoids against Tumor Gamma-Herpesviruses and Their Correlated Cancers-A Focus on EBV and KSHV Life Cycles and Carcinogenesis. Int J Mol Sci 2022;24. [PMID: 36613688 DOI: 10.3390/ijms24010247] [Reference Citation Analysis]
14 Spagnol LW, Polettini J, Silveira DA, Wegner GRM, Paiva DFF. P16 gene promoter methylation is associated with oncogenesis and progression of gastric carcinomas: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 2022;180:103843. [DOI: 10.1016/j.critrevonc.2022.103843] [Reference Citation Analysis]
15 Liang Y, Liu W, Zhao M, Shi D, Zhang Y, Luo B. Nuclear Respiratory Factor 1 Promotes the Progression of EBV-associated Gastric Cancer and Maintains EBV Latent Infection.. [DOI: 10.21203/rs.3.rs-2279263/v1] [Reference Citation Analysis]
16 Wang Q, Guo F, Jin Y, Ma Y. Applications of human organoids in the personalized treatment for digestive diseases. Signal Transduct Target Ther 2022;7:336. [PMID: 36167824 DOI: 10.1038/s41392-022-01194-6] [Reference Citation Analysis]
17 Wyżewski Z, Mielcarska MB, Gregorczyk-zboroch KP, Myszka A. Virus-Mediated Inhibition of Apoptosis in the Context of EBV-Associated Diseases: Molecular Mechanisms and Therapeutic Perspectives. IJMS 2022;23:7265. [DOI: 10.3390/ijms23137265] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zhang L, Wang R, Xie Z. The roles of DNA methylation on the promotor of the Epstein–Barr virus (EBV) gene and the genome in patients with EBV-associated diseases. Appl Microbiol Biotechnol. [DOI: 10.1007/s00253-022-12029-3] [Reference Citation Analysis]
19 Qin N, Zhang Y, Xu L, Liu W, Luo B. Maintenance of Epstein-Barr virus latency through interaction of LMP2A with CXCR4. Arch Virol 2022. [PMID: 35752684 DOI: 10.1007/s00705-022-05511-w] [Reference Citation Analysis]
20 Huang Y, Jiang L, Liu Y, Liu L, Wang J, Shi L. Long non-coding RNAs in virus-related cancers. Rev Med Virol 2022;:e2364. [PMID: 35607835 DOI: 10.1002/rmv.2364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Zhang C, Chong X, Jiang F, Gao J, Chen Y, Jia K, Fan M, Liu X, An J, Li J, Zhang X, Shen L. Plasma extracellular vesicle derived protein profile predicting and monitoring immunotherapeutic outcomes of gastric cancer. J Extracell Vesicles 2022;11:e12209. [PMID: 35362262 DOI: 10.1002/jev2.12209] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Liu D, Shi D, Xu L, Sun L, Liu S, Luo B. LMP2A inhibits the expression of KLF5 through the mTORC1 pathway in EBV-associated gastric carcinoma. Virus Research 2022. [DOI: 10.1016/j.virusres.2022.198792] [Reference Citation Analysis]
23 Lima Á, Sousa H, Medeiros R, Nobre A, Machado M. PD-L1 expression in EBV associated gastric cancer: a systematic review and meta-analysis. Discov Oncol 2022;13:19. [PMID: 35318527 DOI: 10.1007/s12672-022-00479-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zhang J, Du Y, Gong L, Shao Y, Wen J, Sun L, He D, Guo J, Chen J, Shao C. EBV-Induced CXCL8 Upregulation Promotes Vasculogenic Mimicry in Gastric Carcinoma via NF-κB Signaling. Front Cell Infect Microbiol 2022;12:780416. [DOI: 10.3389/fcimb.2022.780416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Dzikowiec M, Lik P, Kiszałkiewicz J, Kuczyńska A, Mordalski M, Nejc D, Piekarski J, Brzeziańska-lasota E, Pastuszak-lewandoska D. Helicobacter pylori and Epstein-Barr Virus Co-Infection in Polish Patients with Gastric Cancer – A Pilot Study. Polish Journal of Microbiology 2022;0. [DOI: 10.33073/pjm-2022-004] [Reference Citation Analysis]
26 Li C, Yang S, Li R, Gong S, Huang M, Sun Y, Xiong G, Wu D, Ji M, Chen Y, Gao C, Yu Y. Dual-Aptamer-Targeted Immunomagnetic Nanoparticles to Accurately Explore the Correlations between Circulating Tumor Cells and Gastric Cancer. ACS Appl Mater Interfaces 2022;14:7646-58. [PMID: 35104098 DOI: 10.1021/acsami.1c22720] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Lv W, Cheng K, Li X, Feng L, Li H, Li J, Chang C, Cao D. Case Report: Favorable Response and Manageable Toxicity to the Combination of Camrelizumab, Oxaliplatin, and Oral S-1 in a Patient With Advanced Epstein-Barr Virus-Associated Gastric Cancer. Front Oncol 2021;11:759652. [PMID: 35096571 DOI: 10.3389/fonc.2021.759652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Ushijima T, Furuichi Y, Takeshima H, Hattori N. Epigenetic Epidemiology of Infectious Diseases. Epigenetic Epidemiology 2022. [DOI: 10.1007/978-3-030-94475-9_14] [Reference Citation Analysis]
29 Yao C, Li Y, Luo L, Xiong Q, Zhong X, Xie F, Feng P. Identification of miRNAs and genes for predicting Barrett's esophagus progressing to esophageal adenocarcinoma using miRNA-mRNA integrated analysis. PLoS One 2021;16:e0260353. [PMID: 34818353 DOI: 10.1371/journal.pone.0260353] [Reference Citation Analysis]
30 Shi D, Zhang Y, Mao T, Liu D, Liu W, Luo B. MiR-BART2-3p targets Unc-51-like kinase 1 and inhibits cell autophagy and migration in Epstein-Barr virus-associated gastric cancer. Virus Res 2021;305:198567. [PMID: 34555439 DOI: 10.1016/j.virusres.2021.198567] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Aguayo F, Boccardo E, Corvalán A, Calaf GM, Blanco R. Interplay between Epstein-Barr virus infection and environmental xenobiotic exposure in cancer. Infect Agent Cancer 2021;16:50. [PMID: 34193233 DOI: 10.1186/s13027-021-00391-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Li W, Okabe A, Kaneda A. Epigenetic aberrations by Epstein–Barr virus infection to develop gastric cancer. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00006-x] [Reference Citation Analysis]